Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medisys to raise $72 million:

This article was originally published in Clinica

Executive Summary

UK company Medisys plans to raise £45 million ($72 million) in a share offering of around 37.6 million shares at 120p per share. The Ipswich-based company will use £17 million for the development and marketing of its Futura safety syringe. It plans to file for US FDA approval shortly. A further £10 million has been set aside for the development and purchase of products to complement Futura. Medisys said it will put around £9 million of the fresh funds into commercialisation of its Dart blood glucose monitoring product.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT075646

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel